Skip to main content
logo
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.314
+0.105 (3.26%)
At close: Jul 31, 2026

BioStem Technologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
37.6547.4869.6616.696.884.34
Revenue Growth
-13.88%-31.84%317.48%142.69%58.38%1284.88%
Gross Profit
33.0844.4455.9215.425.992.87
Operating Income
-14.82-0.6931.12-7.06-4.68-1.61
Net Income
-19.31-6.5831.03-8.48-7.19-1.45
Earnings Per Share
-1.15-0.391.43-0.62-0.63-0.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
13.729.5522.830.240.770.34
Total Debt
3.283.334.394.775.214.89
Net Cash (Debt)
10.4226.2218.44-4.53-4.44-4.55
Net Cash Growth
-53.40%42.20%----
Net Cash Per Share
0.621.570.85-0.33-0.39-0.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
5.049.9424.46-3.50.3-0.11
Capital Expenditures
-3.19-3.35-0.43-0.11-0.24-0.04
Free Cash Flow
1.856.5924.04-3.60.06-0.15
Free Cash Flow Growth
-93.24%-72.59%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
87.87%93.59%80.27%92.44%87.17%66.03%
Operating Margin
-39.37%-1.45%44.68%-42.30%-68.09%-36.99%
Pretax Margin
-38.49%-0.82%43.83%-50.84%-105.19%-32.52%
Profit Margin
-51.28%-13.86%44.55%-50.84%-104.62%-33.30%
FCF Margin
4.92%13.88%34.51%-21.60%0.87%-3.51%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--7.43---
Forward PE
-18.146.858.6223.44-
P/FCF Ratio
30.719.719.59-606.05-
PS Ratio
1.511.353.315.695.292.28